A public comment period is open through June 29, 2026
Engstrom Ruud, L., Pereira, M
van Bloemendaal L, Veltman DJ, ten Kulve JS, Groot PFC, Ruh HG, Barkhof F, et al
The company benefits from deep peptide synthesis expertise, multiple GMP manufacturing facilities, and expanding capabilities to support rising demand for GLP-1-based medicines, strengthening its position in the global semaglutide and tirzepatide supply ecosystem
Toxins from environmental pollutants, processed foods, alcohol consumption, and smoking can deplete glutathione stores in the body
Deep reinforcement learning and its applications in medical imaging and radiation therapy: a survey